# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Edwards Lifesciences (Canada) Inc today announced Health Canada's approval of the company's PASCAL Precision transcathe...
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a...
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $105 t...
Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a In-Line and raises the price target f...